Edition:
United Kingdom

Natus Medical Inc (BABY.OQ)

BABY.OQ on NASDAQ Stock Exchange Global Select Market

29.89USD
13 Nov 2018
Change (% chg)

$0.00 (+0.00%)
Prev Close
$29.89
Open
$29.93
Day's High
$30.33
Day's Low
$29.83
Volume
77,919
Avg. Vol
76,910
52-wk High
$41.55
52-wk Low
$27.70

Chart for

About

Natus Medical Incorporated is a provider of newborn care and neurology healthcare products and services used for the screening, diagnosis, detection, treatment, monitoring and tracking of common medical ailments in newborn care, hearing impairment, neurological dysfunction, epilepsy, sleep disorders, neuromuscular diseases and... (more)

Overall

Beta: 0.88
Market Cap(Mil.): $1,340.90
Shares Outstanding(Mil.): 33.15
Dividend: --
Yield (%): --

Financials

  BABY.OQ Industry Sector
P/E (TTM): 67.43 195.28 33.64
EPS (TTM): 0.60 -- --
ROI: 3.83 9.64 14.22
ROE: 4.58 15.60 15.99

CORRECTED-Hedge fund Voce's nominees elected to Natus board

June 22 Natus Medical Inc said on Friday its stockholders had elected hedge fund Voce Capital Management's nominees to the company's board, ending a months long proxy fight.

24 Jun 2018

UPDATE 1-In Natus proxy fight, Glass Lewis supports Voce nominees

BOSTON, June 13 Influential proxy-advisory firm Glass Lewis & Co recommended that Natus Medical Incorporated shareholders remove two company nominated directors and replace them with hedge fund Voce Capital Management's nominees.

14 Jun 2018

In Natus proxy fight, Glass Lewis supports Voce nominees

BOSTON, June 13 Influential proxy-advisory firm Glass Lewis & Co recommended that Natus Medical Incorporated shareholders remove two company nominated directors and replace them with hedge fund Voce Capital Management's nominees.

13 Jun 2018

Earnings vs. Estimates